The Advocate General proposes the annulment of the provisions requiring pharmaceutical and cosmetics producers to finance at least 80% of the costs associated with quaternary wastewater treatment. Importantly, the Opinion does not challenge the environmental objectives of the Directive, the need to reduce micropollutants in wastewater, nor the legitimacy of introducing quaternary treatment. Instead, it focuses on the scientific and evidentiary basis underpinning the allocatio
